Beaten-up ASX 200 stock rebounds 15%. Macquarie says more to come

The sell-off could be unfounded, one broker says.

| More on:
Modern accountant woman in a light business suit in modern green office with documents and laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Helia Group Ltd (ASX: HLI) shares experienced a strong rebound on Thursday, with the ASX 200 stock currently surging nearly 15% to $3.84 per share.

Yesterday, Helia was heavily sold off following reports Commonwealth Bank of Australia (ASX: CBA) was tendering a long-held contract with the company. It closed at $4.22 per share on Tuesday, before sliding back to $3.34 per share after Wednesday's sell-off.

Today's recovery rally follows an upgrade on the ASX 200 stock from analysts at Macquarie. This has potentially injected a dose of optimism into the beaten-up stock. Let me explain.

ASX 200 stock rebounds

The drop in the ASX 200 stock yesterday was triggered by news that CBA would run a tender for its lenders mortgage insurance (LMI) business. This is a contract it has long held with Helia.

This business also currently contributes about 53% of Helia's gross written premium (GWP). Investors were understandably spooked yesterday, contributing to the downside.

However, Macquarie's analysts suggest that Helia is well-positioned to win this tender once again. The investment bank noted that this is not CBA's first tender, and historically, Helia has managed to retain its contracts.

"[W ]e think HLI would likely win the tender again and be the exclusive LMI writer, [for CBA}", it said in a note, according to The Australian.

If the ASX 200 stock is successful, it could also secure Bankwest, the broker says. This could potentially boost its GWP by 9%.

Macquarie believes the financial impact of losing the contract would be minimal in the short term. The current contract expires at the end of 2025, with revenue impacts not expected until 2027.

The firm's research of recent tenders of similar variety also "suggests with multiple LMI providers generally chose the provider they did the most business with".

Other brokers weigh in

Goldman Sachs also weighed in on the situation in a note yesterday. According to the firm, the tender process with CBA is not a new challenge for the ASX 200 stock. "We note that this is the second time in three years that HLI's Supply and Service contract with CBA has been put up for RFP," it stated.

There should be very limited impact on near-term earnings as HLI will continue to earn GWP from the existing CBA contract until its expiry on 31-Dec-25..

Since successfully winning the last RFP, we understand that HLI has increased the levels of its technology integration with CBA, having largely rebuilt its technology interface.

This perspective aligns with Macquarie's view that any potential financial impact would be felt much later, giving Helia time to adjust.

Goldman has a neutral rating on the ASX 200 stock with a $4.53 per share price target.

Conclusion

Today's rebound in this ASX 200 stock shows that investors are keeping an eye on the tender process. In the last 12 months, Helia shares have held a 13% gain.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Financial Shares

Why did the IAG share price just hit a 5-year high?

Shareholders of this insurance giant are smiling on Tuesday. What's going on?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Financial Shares

What's the outlook for Macquarie shares in 2025?

Here’s an expert view on whether the financial giant can continue its strong run into 2025.

Read more »

Man slipping over on banana skin
Financial Shares

Up 100% in a year, why is this ASX 200 stock slipping on Monday?

This top performing ASX 200 company is sputtering today.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Financial Shares

What is this leading broker saying about the AMP share price?

Do analysts at Goldman Sachs think this blue chip can keep rising?

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Earnings Results

This ASX small-cap stock is up 500% in 2024. Here's why it just crashed

What is disappointing investors today? Let's find out why they are selling this stock.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

This ASX All Ords stock just crashed 23%! Here's why

Investors are sending the ASX All Ords stock tumbling today. But why?

Read more »

An excited man stretches his arms out above his head as he reaches a mountain peak representing two ASX 200 shares reaching multi-year high prices today
52-Week Highs

This ASX 200 stock just hit a 14-year high following an upgrade from Macquarie

You’d have to go all the way back to May 2010 to find the ASX 200 stock trading at higher…

Read more »

Two people shaking hands in the boardroom on a merger.
Financial Shares

IAG share price storms to multi-year high on $855m RACQ deal

The insurance giant has struck a deal that it expects to be earnings accretive.

Read more »